Fast DNA test for sepsis in the ICU
Part of Infections clinical trials.
This study tests a quick DNA-based test to find bloodstream infections in ICU patients. If you are getting standard blood cultures for a suspected infection, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in the intensive care unit (ICU).
- Your doctor has ordered blood cultures because they think you may have a bloodstream infection.
- You are 18 years or older (typically for adult ICU).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new rapid blood test (Cobas Eplex) that may help doctors identify the cause of a bloodstream infection faster than standard methods. If you are an adult or child hospitalized for a blood infection, this study could lead to quicker, more targeted treatment.
This trial tests a new, faster way to find bacteria in the blood of children with suspected sepsis. It uses a molecular test that may give results sooner than standard cultures, helping doctors treat infections more quickly.
This study tests a new rapid test (NuRapid-CRISPR) that quickly identifies the bacteria or fungus causing a serious blood infection in ICU patients. The goal is to help doctors start the right treatment faster and improve patient outcomes.
This study uses a highly sensitive blood test (DdPCR) to quickly find and monitor harmful bacteria in ICU patients with sepsis, aiming to improve early detection and treatment.
This study compares two blood test methods to help predict sepsis (a severe infection) and patient outcomes in the intensive care unit. It may help doctors identify high-risk patients faster and more accurately.
This study tests whether a special blood test can help doctors quickly identify patients who have serious infections (sepsis) in the emergency department. The test looks at white blood cells that glow under fluorescent light to see if they can predict which patients are at highest risk.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.